{"id":"https://openalex.org/W173494530","doi":null,"title":"Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.","display_name":"Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study.","publication_year":2004,"publication_date":"2004-12-03","ids":{"openalex":"https://openalex.org/W173494530","mag":"173494530","pmid":"https://pubmed.ncbi.nlm.nih.gov/15622315"},"language":"en","primary_location":{"id":"pmid:15622315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15622315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020915167","display_name":"David W. Haas","orcid":"https://orcid.org/0000-0002-5813-1594","observed_orcids":["https://orcid.org/0000-0002-5813-1594"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David W Haas","raw_affiliation_strings":["Program for Human Genetics, Vanderbilt University School of Medicine, 345 24th Avenue North, Nashville, TN 37203, USA. david.w.haas@vanderbilt.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program for Human Genetics, Vanderbilt University School of Medicine, 345 24th Avenue North, Nashville, TN 37203, USA. david.w.haas@vanderbilt.edu","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008957693","display_name":"Heather Jane Ribaudo","orcid":"https://orcid.org/0000-0002-0394-3990","observed_orcids":["https://orcid.org/0000-0002-0394-3990"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heather J Ribaudo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007321180","display_name":"Richard B. Kim","orcid":"https://orcid.org/0000-0001-8148-1632","observed_orcids":["https://orcid.org/0000-0001-8148-1632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard B Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112346306","display_name":"Camlin Tierney","orcid":"https://orcid.org/0009-0008-2964-6805","observed_orcids":["https://orcid.org/0009-0008-2964-6805"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Camlin Tierney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015414548","display_name":"Grant R. Wilkinson","orcid":"https://orcid.org/0000-0001-9701-3016","observed_orcids":["https://orcid.org/0000-0001-9701-3016"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grant R Wilkinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062018854","display_name":"Roy M. Gulick","orcid":"https://orcid.org/0000-0002-1431-8912","observed_orcids":["https://orcid.org/0000-0002-1431-8912"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roy M Gulick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088660280","display_name":"David B. Clifford","orcid":"https://orcid.org/0000-0001-5719-1555","observed_orcids":["https://orcid.org/0000-0001-5719-1555","https://orcid.org/0000-0003-4130-4134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David B Clifford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035179969","display_name":"Todd Hulgan","orcid":"https://orcid.org/0000-0002-3339-067X","observed_orcids":["https://orcid.org/0000-0002-3339-067X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Todd Hulgan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047434629","display_name":"Catia Marzolini","orcid":"https://orcid.org/0000-0002-2312-7050","observed_orcids":["https://orcid.org/0000-0002-2312-7050"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catia Marzolini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110221215","display_name":"Edward P. Acosta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward P Acosta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":27.9205,"has_fulltext":false,"cited_by_count":626,"citation_normalized_percentile":{"value":0.99843085,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"18","issue":"18","first_page":"2391","last_page":"400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8184000253677368,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.8184000253677368,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.17759999632835388,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":1.0},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.8199999928474426},{"id":"https://openalex.org/keywords/central-nervous-system-adverse-effects","display_name":"central nervous system adverse effects","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cyp2b6","display_name":"CYP2B6","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.6430000066757202},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.8169999718666077},{"id":"https://openalex.org/keywords/plasma-exposure","display_name":"plasma exposure","score":0.7200000286102295},{"id":"https://openalex.org/keywords/racial-differences","display_name":"racial differences","score":0.5989999771118164},{"id":"https://openalex.org/keywords/african-americans","display_name":"African Americans","score":0.7900000214576721},{"id":"https://openalex.org/keywords/european-americans","display_name":"European Americans","score":0.7960000038146973},{"id":"https://openalex.org/keywords/cyp3a4","display_name":"CYP3A4","score":0.8230000138282776},{"id":"https://openalex.org/keywords/cyp3a5","display_name":"CYP3A5","score":0.9660000205039978},{"id":"https://openalex.org/keywords/mdr1","display_name":"MDR1","score":0.9350000023841858},{"id":"https://openalex.org/keywords/neuropsychological-assessment","display_name":"neuropsychological assessment","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.9761938452720642},{"id":"https://openalex.org/C50605568","wikidata":"https://www.wikidata.org/wiki/Q14912267","display_name":"CYP2B6","level":5,"score":0.638752281665802},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5582637190818787},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5023014545440674},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49920082092285156},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3249399960041046},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23463332653045654},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.14180481433868408},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.13584810495376587},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.1349649727344513},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.08458614349365234},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.0449201762676239},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000163","descriptor_name":"Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002493","descriptor_name":"Central Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002493","descriptor_name":"Central Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002493","descriptor_name":"Central Nervous System Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011110","descriptor_name":"Polymorphism, Genetic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:15622315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15622315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"AIDS (London, England)","raw_type":"Clinical Trial"},{"id":"pmh:oai:edoc.unibas.ch:69537","doi":null,"is_oa":false,"landing_page_url":"https://edoc.unibas.ch/69537/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401836","display_name":"edoc (University of Basel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1850255","host_organization_name":"University of Basel","host_organization_lineage":["https://openalex.org/I1850255"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:serval.unil.ch:BIB_FBA7F629F387","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_FBA7F629F387","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"AIDS, vol. 18, no. 18, pp. 2391-400","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:173494530","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15622315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":null,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.8500000238418579,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1171702575","display_name":"Antiretroviral Therapy for HIV-Infected Patients","funder_award_id":"5k24ai051966-10","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G1355458580","display_name":"COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT","funder_award_id":"5u01ai046386-05","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2207925326","display_name":"ADULT AIDS CLINICAL TRIALS GROUP","funder_award_id":"5u01ai032775-13","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3215204683","display_name":"ADULT AIDS CLINICAL TRIALS UNIT","funder_award_id":"5u01ai025903-18","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3740858242","display_name":"STATISTICAL AND DATA MANAGEMENT CENTER","funder_award_id":"5u01ai038855-09","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4136969905","display_name":"GENERAL CLINICAL RESEARCH CENTER","funder_award_id":"5m01rr000047-47","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G4163140374","display_name":"Vanderbilt Meharry Center for AIDS Research","funder_award_id":"P30AI054999","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5456484914","display_name":"ADULT ACTG CENTRAL GROUP","funder_award_id":"U01AI038858","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5568426178","display_name":"VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT","funder_award_id":"5u01ai046339-05","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G7982882065","display_name":"DETERMINANTS  OF INDIVIDUAL RESPONSIVENESS TO DRUGS","funder_award_id":"5p01gm031304-24","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W199559419","https://openalex.org/W1587094587","https://openalex.org/W1896034128","https://openalex.org/W1981458531","https://openalex.org/W1990565207","https://openalex.org/W1995164644","https://openalex.org/W2006998778","https://openalex.org/W2010015595","https://openalex.org/W2012369574","https://openalex.org/W2041104889","https://openalex.org/W2071086973","https://openalex.org/W2078556370","https://openalex.org/W2080382785","https://openalex.org/W2085038188","https://openalex.org/W2089468994","https://openalex.org/W2098938825","https://openalex.org/W2105902511","https://openalex.org/W2106737113","https://openalex.org/W2131403498","https://openalex.org/W2134294082","https://openalex.org/W2142306898","https://openalex.org/W2148074482","https://openalex.org/W2151774137","https://openalex.org/W2155268095","https://openalex.org/W2169136493","https://openalex.org/W2318289184","https://openalex.org/W2321852728","https://openalex.org/W2329526205","https://openalex.org/W2527229227"],"related_works":["https://openalex.org/W2755604","https://openalex.org/W2164216849","https://openalex.org/W2157533742","https://openalex.org/W2151647473","https://openalex.org/W2147877785","https://openalex.org/W2126546063","https://openalex.org/W2110868212","https://openalex.org/W2109808952","https://openalex.org/W2106737113","https://openalex.org/W2100524797","https://openalex.org/W2098938825","https://openalex.org/W2095442537","https://openalex.org/W2075051244","https://openalex.org/W2071086973","https://openalex.org/W2066614023","https://openalex.org/W2011912864","https://openalex.org/W2001435229","https://openalex.org/W199559419","https://openalex.org/W1981458531","https://openalex.org/W1967951091"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Efavirenz":[1,26,86],"is":[2,27,229],"an":[3],"effective":[4],"antiretroviral":[5],"agent,":[6],"but":[7],"central":[8,47,73,189,259],"nervous":[9,48,74,96,190,260],"system":[10,49,75,97,191,261],"side":[11,50,76,262],"effects":[12,51,77],"occur":[13],"commonly,":[14],"and":[15,21,41,52,78,103,116,138,159,171],"population":[16,206],"(racial)":[17],"differences":[18,207,249],"in":[19,37,83,131,135,208,232,235,250,253],"pharmacokinetics":[20,88],"response":[22],"have":[23],"been":[24],"reported.":[25],"metabolized":[28],"by":[29,91,101],"cytochrome":[30],"P4502B6":[31],"(CYP2B6).":[32],"We":[33],"investigated":[34],"whether":[35],"polymorphisms":[36,221],"CYP2B6,":[38],"CYP3A4,":[39],"CYP3A5,":[40],"MDR1":[42],"were":[43,89,99,216],"associated":[44,140,187,238],"with":[45,141,188,218,239],"efavirenz":[46,79,143,151,242,258],"pharmacokinetics.":[53],"DESIGN:":[54],"Twenty-four":[55],"week":[56,194],"cohort":[57],"from":[58,202],"a":[59,92],"randomized":[60],"study.":[61],"METHODS:":[62],"Adult":[63],"AIDS":[64],"Clinical":[65],"Trials":[66],"Group":[67],"study":[68],"A5097s":[69],"examined":[70],"relationships":[71],"between":[72],"plasma":[80,87,144,243],"concentration-time":[81],"profiles":[82],"HIV-infected":[84],"subjects.":[85],"estimated":[90],"population-based":[93],"method.":[94],"Central":[95],"symptoms":[98,192],"assessed":[100],"questionnaires":[102],"neuropsychological":[104],"testing.":[105],"RESULTS:":[106],"Study":[107],"subjects":[108,204],"included":[109],"89":[110],"(57%)":[111],"European-Americans,":[112],"50":[113],"(32%)":[114],"African-Americans,":[115],"15":[117],"(10%)":[118],"Hispanics.":[119],"The":[120,149,181],"CYP2B6":[121,182,225],"T/T":[122,160],"genotype":[123,161,184],"at":[124,193],"position":[125],"516":[126],"(GlnHis)":[127],"was":[128,139,162,185,237],"more":[129,230],"common":[130,231],"African-Americans":[132,233],"(20%)":[133],"than":[134,234],"European-Americans":[136],"(3%),":[137],"greater":[142,241],"exposure":[145,244],"(P":[146,178,196],"<":[147,179],"0.0001).":[148,180],"median":[150],"[area-under-the-curve]":[152],"(0-24":[153],"h)":[154],"according":[155],"to":[156,257],"G/G,":[157],"G/T,":[158],"44":[163],"(n":[164,168,173],"=":[165,169,174,197],"78),":[166],"60":[167],"60),":[170],"130":[172],"14)":[175],"mug.h/ml,":[176],"respectively":[177],"G516T":[183,212],"also":[186],"1":[195],"0.036).":[198],"Analysis":[199],"of":[200,210],"DNA":[201],"other":[203,220],"confirmed":[205],"frequency":[209],"the":[211,219],"variant.":[213],"No":[214],"associations":[215],"apparent":[217],"studied.":[222],"CONCLUSIONS:":[223],"A":[224],"allelic":[226],"variant":[227],"that":[228],"Europeans-Americans":[236],"significantly":[240],"during":[245],"HIV":[246],"therapy.":[247],"Inter-individual":[248],"metabolism":[251],"may,":[252],"part,":[254],"explain":[255],"susceptibility":[256],"effects.":[263]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":21},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":37},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":33},{"year":2013,"cited_by_count":44},{"year":2012,"cited_by_count":55}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}